Bladder Cancer Doctors Abroad — Page 3

Saban Sec serves as the specialist physician representative for the Turkish Medical Oncology Association, leading the way in urogenital cancer care.

• Specialises in medical oncology for bladder and other urogenital cancers
• Expert in managing chemotherapy and targeted immunotherapy protocols
• Published researcher in prognostic factors for complex tumour cases
• Member of the Turkish Medical Oncology Association and Istanbul Medical Chamber

Associate Professor Turkan Ozturk Topcu is a triple-certified medical oncology specialist at Valued Med Hub Hospitals with prestigious North American training.

• Trained at MD Anderson Cancer Center – one of the world's highest-ranked cancer facilities
• Previously worked at the Sunnybrook Odette Cancer Center Breast Cancer Clinic in Canada
• Completed further oncology training at the Moffit Cancer Center in the USA
• Specialises in managing complex genitourinary malignancies including bladder and kidney cancers
• Experienced in multi-agent chemotherapy protocols for both early and systemic disease

Professor Bunyamin Kaplan is a senior radiation oncologist at Medipol Mega University Hospital, one of Turkey's largest and most reputable medical institutions.

• Specialises in radiation therapy to treat bladder tumours without invasive surgery
• Focuses on curative-intent radiation for patients not suited for radical cystectomy
• Integrates radiotherapy with chemotherapy to improve bladder-sparing outcomes
• Coordinates multidisciplinary care within a JCI-accredited academic hospital setting

Associate Professor Tahsin Ozatli is a medical oncology specialist at Istinye University Liv Hospital with experience in major Turkish oncology hubs.

• Specialises in medical oncology for managing solid tumours including gastrointestinal and urogenital cases
• Former physician at the Ankara Oncology Clinic – one of Turkey's high-volume cancer centres
• Achieved Associate Professor status in 2016 for his contributions to medical education
• Worked at the Erzurum Regional Training and Research Hospital managing complex medical needs

Associate Professor Yusuf Acikgoz is a specialist medical oncologist at Lokman Hekim University with international experience at the Ohio State University.

• Specialises in systemic therapies for bladder cancer including chemotherapy and immunotherapy
• Assistant investigator for major Phase III clinical trials evaluating new cancer treatments
• Completed specialised immuno-oncology training through the Central European Cooperative Oncology Group
• Active member of the American Society of Clinical Oncology (ASCO)
• Qualified in biostatistics to ensure evidence-based treatment protocols for complex cases

Professor Cemil Bilir is a leading medical oncologist at VM Medical Park Pendik with dual expertise in clinical treatment and pharmacy-based biotechnology.

• Completed a research fellowship at the Center for Pharmaceutical Biotechnology and Nanomedicine in Boston
• Published extensive research on inorganic chemistry to improve drug delivery for cancer patients
• Member of the European Society for Medical Oncology (ESMO) following international guidelines
• Specialises in chemotherapy and targeted biological therapies for internal malignancies

Associate Professor Nail Paksoy is a highly published medical oncologist and a European Society for Medical Oncology (ESMO) board-certified specialist.

• Specialises in immunotherapy with Atezolizumab for metastatic urothelial carcinoma – a form of bladder cancer
• Research focus on prognostic factors that predict treatment outcomes in advanced bladder cancer cases
• Uses targeted PRRT therapy to treat neuroendocrine tumours with precision radiation
• Served as a sub-investigator for major international clinical trials with Roche and Pfizer
• Board-certified by the European Society for Medical Oncology in Paris

Assoc. Prof. Ayşe İrem Yasin, M.D., is a medical oncologist who specializes in solid tumors. Her clinical focus includes breast, lung, gastrointestinal, gynecologic, and urologic cancers. She also treats brain and other CNS tumors, soft tissue sarcomas, head and neck cancers, adenocarcinomas, melanoma, Merkel cell carcinoma, and cancers of unknown primary. She practices at Medipol Acıbadem District Hospital (2025–present). She previously worked at Şişli Etfal Training and Research Hospital (2023–2025).

She completed a Medical Oncology fellowship at Bezmialem Vakıf University (2019–2022). This followed an Internal Medicine residency at the same institution (2012–2016). Her international experience includes the Breast Cancer Unit at the University of Piemonte Orientale in Novara (2022). She also trained at Basel University Hospital, Cleveland Clinic, and Harvard Medical School. She holds the ESMO Board Certificate (2022).

Assoc. Prof. Atakan Topçu, M.D., is a medical oncologist at Medipol University and Medipol Acıbadem Regional Hospital. He treats solid tumors, including lung, breast, colorectal, gastric, and neuroendocrine cancers. His work also covers targeted therapies, immunotherapy, geriatric oncology, and cancer-related malnutrition, cachexia, and sarcopenia.

He has authored more than 50 peer-reviewed papers. Recent work includes a 2024 Frontiers in Medicine study on geriatric syndromes and a 2023 Future Oncology paper on sarcopenia and anxiety in lung cancer. He has also published on the CONUT score in breast cancer and on malnutrition in HER2-negative metastatic gastric cancer.

Dr. Topçu serves on the Editorial Board of BMC Cancer. He is a member of the Turkish Society of Medical Oncology, ESMO, and the Turkish Geriatrics Society. Education and training: M.D., Uludağ University; residency in Internal Medicine, Marmara University; fellowship in Medical Oncology, Bezmialem Vakıf University.

Associate Professor Mustafa Serkan Alemdar is a medical oncology specialist at Medical Park Antalya Hospital Complex who leads systemic therapy for urological malignancies.

• Specialises in chemotherapy and immunotherapy for advanced bladder cancer cases
• Served at Akdeniz University Hospital – a major hub for oncological research
• Member of the Turkish Society of Medical Oncology
• Manages complex medication protocols to target tumours and prevent recurrence
• Expert in palliative supportive care for patients with stage IV disease

Dr. Irfan Cicin is a Professor of Medical Oncology at the Trakya University Faculty of Medicine (2015–present). He has over 20 years of medical oncology experience and has held academic roles since 2010.

Education: MD, Istanbul University – Cerrahpaşa (1991–1997). Residency in Internal Medicine, Trakya University (1997–2002). Fellowship in Medical Oncology, Trakya University (2002–2004).

Practice: Medical Oncologist, Trakya University (2005–2008). Medical Oncologist, Elazığ Training and Research Hospital (2008–2010). Associate Professor of Medical Oncology, Trakya University (2010–2015). He previously served as a physician in the Turkish Air Force at Etimesgut Military Hospital (2004–2005).